Acrospire Investment Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-3,400
| Closed | -$63K | – | 1770 |
|
|
2017
Q2 | $63K | Sell |
3,400
-4,200
| -55% | -$77.8K | 0.06% | 638 |
|
|
2017
Q1 | $171K | Sell |
7,600
-3,600
| -32% | -$81K | 0.14% | 79 |
|
|
2016
Q4 | $390K | Sell |
11,200
-2,300
| -17% | -$80.1K | 0.16% | 67 |
|
|
2016
Q3 | $331K | Buy |
13,500
+3,900
| +41% | +$95.6K | 0.22% | 10 |
|
|
2016
Q2 | $230K | Sell |
9,600
-2,600
| -21% | -$62.3K | 0.17% | 32 |
|
|
2016
Q1 | $285K | Buy |
+12,200
| New | +$285K | 0.2% | 62 |
|